1. Cannabis-based product use in a multiple sclerosis cohort. Issue 3 (September 2019) Authors: Schabas, AJ; Vukojevic, V; Taylor, C; Thu, Z; Badyal, A; Chan, JK; Devonshire, V; Traboulsee, A; Sayao, AL; Carruthers, R Journal: Multiple sclerosis journal, experimental, translational and clinical Issue: Volume 5:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.080 Cognitive Profile, Disease Characteristics, and Neuroimaging Findings in Susac Syndrome: A Case Series of Seven Participants from British Columbia. (November 2021) Authors: Chivukula, P; Chan, J; Johnson, P; Bower, G; Li, D; Lee, J; Vavasour, I; Traboulsee, A; Laule, C; Kolind, S; Woolfenden, A; Carruthers, R Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.091 Consensus Guidelines for Utilization and Monitoring of Intravenous Immunoglobulin for Central Nervous System Disorders in British Columbia. (November 2021) Authors: Uy, CE; Cross, HM; Percy, J; Schrader, D; Carruthers, R; Traboulsee, A; Beauchamp, A; Shih, AW; Morrison, D; Chapman, KM; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P.108 Use of intravenous immunoglobulin for central nervous system disorders in British Columbia: consensus guidelines. (June 2022) Authors: Uy, C; Cross, HM; Percy, J; Schrader, D; Carruthers, R; Traboulsee, A; Beauchamp, A; Shih, A; Morrison, D; Chapman, K; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗